OPINION
WRIGHT, Judge:
Respondent determined the following deficiencies in petitioner’s Federal income taxes:
Year Deficiency
1979. $194,794
1981. 233,956
1982. 812,906
1983. 832,559
After concessions, the deficiency determined for taxable year 1979 is no longer in issue. The issues remaining for decision with respect to taxable years 1981, 1982, and 1983 are:
(1) Whether the research and development expense allocation moratorium under section 223 of the Economic Recovery Tax Act of 1981 (sec. 223 of ERTA), Pub. L. 97-34, 95 Stat. 172, 249, is applicable to the computation of combined taxable income;
(2) whether research and development expenses attributable to medical devices which were never placed into production or offered for sale are allocable and apportion-able as provided by section 1.861-8(e)(3), Income Tax Regs., in computing combined taxable income for purposes of the domestic international sales corporation (DISC) intercompany pricing rules and, if so;
(3) whether section 1.861-8(e)(3), Income Tax Regs., as incorporated by section 1.994-l(c)(6)(iii), Income Tax Regs., for purposes of the DISC intercompany pricing rules, is an invalid regulation:
(a) to the extent it requires allocation of research and development expenses using Standard Industrial Classification (SIC) product categories for the computation of combined taxable income;
(b) to the extent it prohibits an allocation of research and development expenses using industry and trade usage product categories;
(c) to the extent it precludes the use of the “wholesale trade category” in allocating research and development expenses; and
(d) to the extent it precludes the use of the “exclusive geographic apportionment method” in apportioning research and development expenses.
The parties submitted this case fully stipulated pursuant to Rule 122.1 The stipulation of facts, supplemental stipulation of facts, and attached exhibits are incorporated herein.
Petitioner, a Minnesota corporation, had its principal place of business in St. Paul, Minnesota, when its petition was filed. Petitioner is an accrual basis, calendar year taxpayer which develops, manufactures, and sells medical products. Petitioner’s only product during the years at issue was an artificial heart valve. Generally, in the medical products business foreign sales precede domestic sales because of the time required to obtain Food and Drug Administration clearance to market medical products in the United States. Petitioner obtained clearance to market its heart valves in the United States on December 17, 1982.
On December 20, 1979, petitioner initiated a research and development project in order to produce a cardiac pacemaker. Due to escalating costs and startup problems, petitioner terminated its effort to develop the cardiac pacemaker in March of 1981. In April of 1980, petitioner entered into a joint research and development project in order to produce an implantable insulin pump. Petitioner abandoned its effort to develop implantable insulin pumps in 1983. No sales of a cardiac pacemaker or insulin pump were ever attempted by petitioner or its subsidiaries. Cardiac pacemakers, insulin pumps, and heart valves constitute separate products or product lines under recognized industry or trade usage in the medical goods manufacturing industry.
On April 20, 1980, petitioner incorporated St. Jude International Sales Corp. (International), a wholly owned subsidiary, for the purpose of qualifying it as a DISC and obtaining the tax deferral advantages available pursuant to the DISC provisions. International, an accrual basis taxpayer, operated on a January 31 fiscal year. Pursuant to a DISC commission agreement, petitioner was to pay International the maximum commission allowable under section 994 and the applicable regulations for all export sales of petitioner’s product. International qualified as a DISC under section 992 during its fiscal years 1981 through 1984. International incurred no research and development expenses during the years in issue.
Petitioner’s total sales, domestic sales, export commission sales, and the percentage of export commission sales to total sales during calendar year 1981, 1982, and 1983 were:
Total Domestic
Year sales sales
1981 $13,206,395 $4,953,507
1982 17,528,098 6,285,996
1983 25,624,428 11,847,468
Export commission sales involving International $8,252,888 11,242,102 13,776,960
% of export sales to total sales 62.48% 64.14 53.76
During each year at issue, 100 percent of petitioner’s research and development activity was performed in the United States. Because the terms of sale for International were f.o.b., St. Paul, Minnesota, International bore the expense and risk of loss of putting a shipment into possession of the carrier.
A preliminary requirement in determining the tax deferral benefits available to petitioner through section 944(a)(2) of the DISC intercompany pricing rules is the computation of the “combined taxable income” of petitioner and International. Combined taxable income equals the excess of the gross receipts of the DISC from export commission sales over the total costs of the DISC and its related supplier (petitioner) which relate to the gross receipts. In computing combined taxable income, petitioner failed to allocate any of the research and development expenses attributable to the cardiac pacemaker and the insulin pump to gross receipts from export sales. In addition, petitioner failed to allocate 30 percent of the research and development expenses attributable to the heart valve between gross receipts from export sales and all other gross receipts:
R&D Allocated Exclusively to All Other Gross Receipts
Description
Implantable insulin pump Implantable cardiac pacemaker 30% exclusive apportionment Cost of terminating implantable insulin pump development Total
International fiscal year ending
1/31/82 1/31/83 1/31/84
$390,217 390,121
87,719 $451,123 $552,200
655,806
1,523,863 451,123 552,200
Respondent recomputed combined taxable income by allocating additional research and development expenses between gross receipts from export sales and all other gross receipts:
Additional research and development expenses International allocated in computing
fiscal year ending combined taxable income
1/31/82. $1,523,863
1/31/83. 451,123
1/31/84. 552,200
The effect of respondent’s determination is to reduce the combined taxable income of petitioner and International during the years in issue, which in turn reduces the amount of commissions deemed paid to International pursuant to section 994(a)(2) by $508,600 in 1981, $143,202 in 1982, and $135,582 in 1983. The reduction in commissions deemed paid to International reduces the amount of income eligible for tax deferral through the DISC provisions. In addition, the reduction in commissions deemed paid reduces the deemed distribution from International to petitioner pursuant to section 995 by $239,353 in 1982, and $69,933 in 1983.
The DISC Provisions
As part of the Revenue Act of 1971, Pub. L. 92-178, 85 Stat. 497, Congress enacted the DISC provisions (secs. 991 through 997) to stimulate exports and grant a Federal income tax deferral opportunity to U.S. firms engaged in exporting through domestic corporations, rather than foreign subsidiaries. H. Rept. 92-533 (1971), 1972-1 C.B. 498, 502, 529.
A DISC is not hable for Federal income tax on its taxable income. Sec. 991. Instead, the Disc’s shareholders are taxed each year on a specified portion of its earnings and profits as deemed distributions. Sec. 995. The retained earnings and profits of a DISC that are not taxed currently remain exempt from taxation until actually distributed to the shareholders, as provided in section 996(a)(1), until a shareholder disposes of his DISC stock in a taxable transaction, as provided in section 995(c), or until the corporation ceases to qualify as a DISC, as provided in section 995(b)(2).
For an entity to qualify as a DISC, a variety of requirements under section 992 must be satisfied. See generally Dresser Industries v. Commissioner, 92 T.C. 1276, 1280 (1989), affd. in part, revd. in part 911 F.2d 1128 (5th Cir. 1990). An entity which qualifies as a DISC is treated as a separate corporation for Federal tax purposes even though it would not otherwise be treated as a corporation for Federal tax purposes. Sec. 1.9924(a), Income Tax Regs.
Intercompany Pricing Rules
Section 994(a) provides three methods of computing the transfer price at which a related supplier is deemed to have sold its products to a DISC, regardless of whether any price is actually paid. Section 994(a) provides:
SEC. 994(a). In General. — In the case of a sale of export property to a DISC by a person described in section 482, the taxable income of such DISC and such person shall be based upon a transfer price which .would allow such DISC to derive taxable income attributable to such sale (regardless of the sales price actually charged) in an amount which does not exceed the greatest of—
(1) 4 percent of the qualified export receipts on the sale of such property hy the DISC plus 10 percent of the export promotion expenses of such DISC attributable to such receipts.
(2) 50 percent of the combined taxable income of such DISC and such person which is attributable to the qualified export receipts on such property derived as the result of a sale by the DISC plus 10 percent of the export promotion expenses of such DISC attributable to such receipts, or
(3) taxable income based upon the sale price actually charged (but subject to the rules provided in section 482).
Petitioner determined its transfer price in accordance with section 994(a)(2), the “50-50 combined taxable income” method. This method permits a DISC to earn 50 percent of the “combined taxable income” of the DISC and its related supplier. Petitioner is the related supplier of International. The DISC is also permitted to earn 10 percent of any export promotion expenses, which are not at issue.
A DISC may operate on a “buy-sell” basis (by taking title to the property to be exported) or on a commission basis (under which it functions as a commission agent for export sales). Brown-Forman Corp. v. Commissioner, 94 T.C. 919, 946 (1990). Although the three intercompany pricing methods contained in section 994(a) literally apply only to Disc’s operating on a “buy-sell” basis, section 994(b)(1) provides that rules consistent with those set forth in section 994(a) shall be prescribed by regulation for Disc’s operating on a commission basis:
SEC. 994(b). Rules for Commissions, Rentals, and Marginal COSTING. — The Secretary shall prescribe regulations setting forth—
(1) rules which are consistent with the rules set forth in subsection (a) for the application of this section in the case of commissions, rentals, and other income * * *
International operated on a commission basis with respect to heart valves exported by petitioner.
Computation of Combined Taxable Income
The term “combined taxable income,” which appears in section 994(a)(2) and (b)(2), is not defined in the Internal Revenue Code. Section 1.994-l(c)(6), Income Tax Regs., defines combined taxable income as:
the excess of the gross receipts (as defined in section 993(f)) of the DISC from such sale over the total costs of the DISC and related supplier which relate to such gross receipts. * * * In determining the gross receipts of the DISC and the total costs of the DISC and related supplier which relate to such gross receipts, the following rules shall be applied: * * * * * * *
(ii) Cost of goods sold shall be determined in accordance with the provisions of sec. 1.61-3. See sections 471 and 472 and the regulations thereunder with respect to inventories. * * *
(iii) Costs (other than costs of goods sold) which shall be treated as relating to gross receipts from sales of export property are (a) the expenses, losses, and other deductions definitely related, and therefore allocated and apportioned, thereto, and (b) a ratable part of any other expenses, losses, or other deductions which are not definitely related to a class of gross income, determined in a manner consistent with the rules set forth in section 1.861-8.
Thus, in computing combined taxable income, costs relating to gross receipts are to be determined in a manner consistent with the rules of section 1.861-8, Income Tax Regs. Section 1.994-l(c)(6)(iii), Income Tax Regs., was issued in 1975, 4 years after the enactment of the DISC provisions. 40 Fed. Reg. 29826, 29828-29829 (July 16, 1975). Section 1.994-l(c)(6)(iii), Income Tax Regs., which is applicable only to a buy/sell DISC, is incorporated for purposes of a commission DISC by section 1.994-l(d)(2), Income Tax Regs., which provides:
(2) Commissions. If any transaction to which section 994 applies is handled on a commission basis for a related supplier by a DISC and such commissions give rise to qualified export receipts under section 993(a)— * * * * * * *
(ii) The maximum commission the DISC may charge the related supplier is the sum of the amount of income determined under subdivision (i) of this subparagraph plus the DISC’s total costs for the transaction as determined under paragraph (c)(6) of this section.
In the case of a commission DISC, “gross receipts” equals the gross receipts on the sale, lease, or rental of the property on which the commissions arose. Sec. 993(f).
Section 1.861-8 Allocation and Apportionment Regulations
Section 1.861-8, Income Tax Regs., provides rules for determining the taxable income of a taxpayer from specific sources and activities under various sections of the Internal Revenue Code, referred to in section 1.861-8, Income Tax Regs., as “operative sections.” Secs. 1.861-8(a)(l), (f), 1.862-1(b), Income Tax Regs.
Operative sections require a computation of taxable income from a “statutory grouping” and a “residuary grouping.” The term “statutory grouping” means the gross income from the specific source or activity which must first be determined in order to arrive at taxable income from such specific source or activity. Gross income from other sources or activities is referred to as the “residuary grouping.” Sec. 1.861-8(a)(4), Income Tax Regs. For example, with respect to the computation of taxable income from sources within the United States, the statutory grouping is gross income from sources within the United States, while all remaining gross income composes the residuary grouping. With respect to the computation of combined taxable income under section 994(a), the statutory grouping is gross income from export sales, while the residuary grouping is all remaining gross income.
A taxpayer must allocate deductions to the appropriate class of gross income and then, if necessary to make the determination required by the operative section, must apportion deductions within the class of gross income between the statutory grouping and the residual grouping. Sec. 1.861-8(a)(2), Income Tax Regs. Allocation is accomplished by determining, with respect to each deduction, the class of gross income to which the deduction is “definitely related” and then allocating the deduction to that class of gross income. A deduction is considered “definitely related” to a class of gross income and therefore allocable to such class if it is incurred as a result of, or incident to, an activity or in connection with property from which such class of gross income is derived. Sec. 1.861-8(b)(2), Income Tax Regs.
However, some deductions Eire treated as “not definitely related to Einy gross income,” and are ratably apportioned to all gross income. Sec. 1.861-8(b)(l), Income Tax Regs. The deductions which Eire not definitely related to any gross income are the deduction allowed by section 163 for interest, the deduction allowed by section 164 for real estate taxes on a personal residence or for sales tax on the purchase of items for personal use, the deduction for medical expenses allowed by section 213, the deduction for charitable contributions allowed by sections 170, 873(b)(2), and 882(c)(1)(B), and the deduction for alimony payments allowed by section 215. Sec. 1.861-8(e)(9), Income Tax Regs.
Where a deduction has been allocated to a class of gross income which is included in both the statutory grouping and the residual grouping, the deduction must be apportioned between the statutory grouping and the residual grouping. If the class of gross income to which a deduction has been allocated is included in its entirety in either a single statutory grouping or the residual grouping, there is no need to apportion that deduction. Sec. 1.861-8(c)(l), Income Tax Regs.
A deduction is apportioned by attributing the deduction between gross income which is in the statutory grouping and gross income which is in the residual grouping. The attribution must be accomplished in a manner which reflects to a “reasonably close extent” the factual relationship between the deduction and the grouping of gross income. Sec. 1.861-8(c)(l), Income Tax Regs.
Allocation and Apportionment of Research and Development Expenses
Section 1.861-8(e)(2) through (8), Income Tax Regs., provides special rules for allocation and apportionment of deductions for interest, research and development expenses, and certain other deductions. Section 1.861-8(e)(3), Income Tax Regs., deals specifically with allocation and apportionment of research and development expenses.
Section 1.861-8(e)(3)(i)(A), Income Tax Regs., provides that research and development expenses relating to products^ within a 2-digit major SIC code category (enumerated by the Executive Office of the President, Office of Management and Budget) are considered deductions which are “definitely related to all income” reasonably connected with the relevant product category and must be allocated to all items of gross income as a class related to the product category.2
Section 1.861-8(e)(3)(i)(A), Income Tax Regs., lists 89 “SIC major goups,” comprised of 32 product categories. A product category may consist of as few as 1 or as many as 15 SIC major groups. The relevant product category (hereinafter referred to as the medical goods category), which is comprised of one SIC major group, number 38, consists of: measuring, analyzing, and controlling instruments; photographic, medical, and optical goods; and watches and clocks. Cardiac pacemakers and insulin pumps, which petitioner attempted to develop, and prosthetic heart valves, which petitioner manufactured and sold, all fall within the medical goods category.
Under section 1.861-8(e)(3), Income Tax Regs., an item of income need not exist for a particular product within a product category as a prerequisite to allocating research expenses to that product. All that is required is that an item of gross income exist as to any product within the same product category. Sec. 1.861-8(e)(3)(ii)(A) and (iii), Income Tax Regs. Thus, the research and development expenses attributable to the insulin pump and cardiac pacemaker ventures must be allocated between the statutory grouping of gross income from export sales and the residuary grouping of all other gross income in computing the combined taxable income of petitioner and International even though the items were never fully developed or marketed.
The final section 1.861-8, Income Tax Regs., which petitioner challenges, was issued in 1977. 42 Fed. Reg. 1195 (Jan. 3, 1977). The section 1.861-8, Income Tax Regs., in effect when Congress enacted the DISC provisions was issued in 1957. 22 Fed. Reg. 8362 (Oct. 23, 1957). None of the regulations under section 1.861-8, Income Tax Regs., final or proposed, which preceded the regulations at issue required that research and development expenses be allocated among SIC product categories.
1. Whether the Research and Development Expense Allocation Moratorium Under Section 223 of ERTA is Applicable to the Computation of Combined Taxable Income
Petitioner, and Intel Corp. (Intel) in its amicus curiae brief, argues that the research and development expense allocation moratorium provided by section 223 of ERTA permits the exclusion of 100 percent of research and development expenses from the combined taxable income computation.3 Thus, petitioner and Intel contend none of petitioner’s research and development expenses, including those attributable to heart valves, should be allocated to gross income from export sales.
Section 223(a) of ERTA suspended the application of the allocation and apportionment rules under section 1.861-8(e)(3), Income Tax Regs., by requiring, for a 2-year period, that all expenditures for research and development activities conducted in the United States be allocated and apportioned exclusively to sources within the United States:
(a) 2-Year Suspension. — In the case of the taxpayer’s first 2 taxable years beginning within 2 years after the date of the enactment of the Act, all research and experimental expenditures (within the meaning of section 174 of the Internal Revenue Code of 1954) which are paid or incurred in such year for research activities conducted in the United States shall be allocated or apportioned to sources within the United States.
Section 223(b) of ERTA directs the Treasury to conduct a study with respect to the impact which section 1.861-8, Income Tax Regs., would have on research and experimental activities conducted in the United States, and on the availability of the foreign tax credit:
(b) Study.—
(1) In general. — The Secretary of the Treasury shall conduct a study with respect to the impact which section 1.861-8 of the Internal Revenue Service Regulations would have (A) on research and experimental activities conducted in the United States and (B) on the availability of the foreign tax credit.
The Treasury study called for by section 223 of ERTA was published in June of 1983. In the study the Secretary reports that section 223 of ERTA did not reduce research and development allocations to combined taxable income. Department of the Treasury, The Impact of the Section 861-8 Regulation on U.S. Research and Development 17 n.7 (June 1983).
In enacting section 223 of ERTA, Congress focused its concern on the foreign tax credit impact of the geographic allocation of research expenses:
A fundamental principle of the foreign tax credit is that it may not be used to offset the U.S. tax on U.S. source income. The foreign tax credit provisions contain a limitation that insures that the credit will not be used to offset the U.S. tax on U.S. source income. Under the limitation, a U.S. taxpayer is allowed a credit against its U.S. tax for foreign taxes paid on foreign source income only to the extent of the pre-credit U.S. tax on the foreign source income. [H. Rept. 97-201, at 130 (1981).]
And further, under the heading “Treasury regulation sec. 1.861-8”:
In determining foreign source taxable income for purposes of computing the foreign tax credit limitation, sections 861-863 require taxpayers to allocate or apportion all of their expenses between foreign source income and U.S. source income. Treasury Regulation section 1.861-8 sets forth the rules on allocating and apportioning these expenses. [H. Rept. 97-201, supra at 130.]
The portion of the House report appearing under the heading “Reasons for Change” also focuses on the foreign tax credit limitation:
Taxpayers that allocate research and development expenses for purposes of the foreign tax credit claim that the allocation results in more deductions being allocated overseas than is allowed as a deduction by the foreign country. Thus, taxpayers claim that their foreign tax credit limitation is lower than the foreign taxes paid and that they will lose foreign tax credits.
Taxpayers argue that because of the application of the regulation, they must transfer research and development activities to the foreign country in order to get a deduction in that country and, thus, get a full foreign tax credit on the income earned in that country.
[H. Rept. 97-201, supra at 131.]
Respondent contends that section 223 of ERTA is inapplicable to the computation of combined taxable income. In addition to the legislative history of section 223 of ERTA, which focuses on the foreign tax credit, respondent relies on his analysis in Rev. Rui. 86-144, 1986-2 C.B. 101.
In Rev. Rui. 86-144, respondent reasons that the geographic sourcing of income is not relevant to the computation of combined taxable income:
Section 1.861-8 of the regulations provides rules for the allocation and apportionment of expenses and deductions (e.g., R&D expenses). Under Example 23 of section 1.861-8(g), R&D expenses are allocated and apportioned in two stages. In the first stage, R&D expenses are apportioned in order to calculate CTI for DISC and FSC [foreign sales corporation] purposes by treating the FISC or FSC and its related supplier as a single taxpayer. Section 1.861-8(f)(l)(iii) and Example 23 of Section 1.861-8(g). In the second stage, R&D expenses are apportioned for purposes of calculating the foreign tax credit limitation under section 904. Section 1.861-8(f)(l)(i).
The computation of CTI (first stage) does not involve geographic sourcing of income. It requires apportionment of R&D expenses between the statutory grouping of gross income from exports and other gross income. The sourcing of the income as United States source or foreign source is irrelevant when allocating deductions for purposes of determining CTI. On the other hand, geographic sourcing of income is required for purposes of calculating the foreign tax credit limitation in the second stage of apportionment.
[1986-2 C.B. 101, 102.]
Respondent then discusses the congressional purpose in enacting section 223 of ERTA:
The moratorium under section 223 of ERTA 81 was enacted because of Congressional concern that the allocation and apportionment of R&D expenses under section 1.861-8 of the regulations could cause research activities performed in the United States to be moved abroad. The same concerns that resulted in the ERTA 81 legislation were present when Congress extended the moratorium by enacting section 126 of TRA 84. Prior to the moratorium, a percentage of' all R&D expenses was apportioned between the U.S. and foreign source income. Section 1.861-8(e)(3). Expenses apportioned to foreign source income generally reduce the amount of the foreign tax credit by operation of the limitation contained in section 904. In order to encourage domestic research activities, Congress enacted the moratorium requiring the allocation or apportionment of domestic research and experimental expenses against U.S. source income. This allocation method provides a benefit to taxpayers performing research in the United States by increasing the amount of the foreign tax credit limitation. [1986-2 C.B. 101, 102.]
Respondent concludes that section 223 of ERTA is inapplicable to the computation of combined taxable income:
The determination of CTI differs from that of foreign source taxable income. CTI determines the relative amount of income earned by a DISC or FSC and its related supplier from the export of U.S. manufactured goods and, thereby, the tax benefit derived from the export transaction. A taxpayer may derive gross receipts qualifying for DISC or FSC treatment, calculate CTI, and claim the related tax benefits with respect to export transactions irrespective of whether they generate foreign source or domestic source income. Therefore, the sourcing of income is not relevant for purposes of calculating CTI.
The moratorium enacted in section 223 of ERTA 81 and continued in section 126 of TRA 84 revised the allocation and apportionment of R&D expenses for identical reasons i.e., in order to modify the calculation of foreign source taxable income and adjust the foreign tax credit limitation. The moratorium was not intended to modify the amount of DISC or FSC benefits derived from export transactions and, therefore, does not apply to the determination of CTI.
[1986-2 C.B. 101, 102-103.]
A revenue ruling is not binding on this Court, since it only represents the contention of one party to a case. United States v. Larionoff, 431 U.S. 864, 873 (1977); Pacific Gas & Electric Co. v. United States, 664 F.2d 1133 (9th Cir. 1981). However, we find that respondent’s position, as expressed in Rev. Rul. 86-144, supra, is correct and in keeping with Congress’ purpose in enacting section 223 of ERTA.
Petitioner contends that respondent unreasonably narrows the scope of section 223 of ERTA, citing the conference committee report accompanying ERTA, which in discussing the Senate amendment provides that, during the 2-year moratorium under section 223, research and development expenses attributable to research activities conducted in the United States are to be allocated and apportioned “to U.S. source income for all purposes under the Code.” H. Rept. 97-215 (1981), 1981-2 C.B. 481, 496.
We find that the statement which petitioner cites is in keeping with respondent’s interpretation of section 223 of ERTA. The moratorium was intended to apply for all purposes for which geographic sourcing is relevant. Because geographic sourcing of income is not an element in the computation of combined taxable income, the moratorium is inapplicable to a DISC.
The moratorium established by section 223 of ERTA was extended for another 2 years by section 126 of the Deficit Reduction Act of 1984 (sec. 126 of DEFRA), Pub. L. 98-369, 98 Stat. 494, 648. Petitioner argues that the legislative history of section 126 of DEFRA demonstrates Congress’ intent to narrow the broad original research and development expense allocation moratorium, which was applicable to the computation of combined taxable income, to one that applied only to the computation of the foreign tax credit limitation. There would have been no need for Congress to amend the moratorium in 1984, petitioner argues, if section 223 of ERTA did not apply to a DISC.
However, section 126 of DEFRA was an extension of section 223 of ERTA, not an amendment. While the DEFRA conference report refers to a “clarification” of the Senate bill’s effective date, it does not treat section 126 of DEFRA as other than an extension of the original moratorium. The conference report states:
The moratorium [section 223 of ERTA] generally expires for taxable years following a taxpayer’s second taxable year commencing after August 13, 1981.
♦ * sfc * * * *
The Senate amendment effectively extends for two years the moratorium on the application of the research and experimental expense allocation rules of Treas. Reg. sec. 1.861-8. * * *
The conference agreement follows the Senate amendment with a clarification of the effective date provision. The conference agreement provides that the extension of the moratorium on application of the Treasury’s research and experimental expense allocation rule will generally apply to a taxpayer’s taxable years beginning after August 13, 1983 and before August 1, 1985. However, in the event the taxpayer’s third taxable year commencing after August 13, 1981 does not begin during this period, the extension of the moratorium applies to that taxable year also.
The moratorium applies only to the allocation of research expenses for the purpose of geographic sourcing of income. It does not apply for other purposes, such as the computation of combined taxable income of a DISC (or FSC) and its related supplier.
[H. Rept. 98-861 (1984), 1984-3 C.B. (Vol. 2) 1, 517; emphasis added.]
Significantly, the conference report refers to section 223 of ERTA as “the moratorium,” while it refers to section 126 of DEFRA as “the extension of the moratorium.” The conference committee’s terminology indicates that: (1) It considered section 126 of DEFRA as an extension of section 223 of ERTA, not an amendment, and (2) section 223 of ERTA (the moratorium) was inapplicable to the computation of combined taxable income because it applied only for purposes of geographic sourcing of income, which is not an element of the computation. The conference report provides substantial support for respondent’s analysis.
Section 13211 of the Consolidated Omnibus Budget Reconciliation Act of 1985, Pub. L. 99-272, 100 Stat. 82, 324, extended the moratorium for 1 year. Other than the effective dates of the moratorium, section 13211 made no changes.
Section 1216 of the Tax Reform Act of 1986, Pub. L. 99-514, 100 Stat. 2085, 2549, provided that for purposes of sections 861(b), 862(b), and 863(b), 50 percent of all qualified research and experimental expenditures were to be apportioned to income from sources within the United States and deducted from such income in determining the amount of taxable income from sources within the United States, while the remaining portion was to be apportioned on the basis of gross sales or gross income.
The House Ways and Means Committee report discusses its view that the moratorium established by section 223 of ERTA should not be renewed:
As a matter of tax policy, the committee is of the view that it is appropriate to require the allocation of deductible expenses (including research expenses) between U.S. and foreign source income. * * * Accordingly, the committee has decided not to renew the expired moratorium on the application of the Treas. Reg. sec. 1.861-8 research expense allocation rules.
*******
While the committee and Congress study these issues further (for a two-year period), the bill provides temporary rules for allocation of research expense that are based on the approach of the Treasury regulation, but that liberalize the Treasury regulation in certain respects. * * * The temporary modifications do not reflect a judgment by the committee that any provision of the existing Treasury research expense allocation rules is necessarily inadequate or inappropriate.